John Littlechild - Profile and Investment Details

Investor Profile

John Littlechild is a Venture Capital, Private Equity Firm based in Cambridge, Massachusetts, United States with a diverse investment portfolio that includes companies such as Apofore, Catalyst Biosciences, Avidia, Proteostasis Therapeutics, GlobeImmune, DecImmune Therapeutics, Colorescience, Stemgent, Mosaic Biosciences, Tensha Therapeutics, Xanodyne, Orqis Medical, Endomedix, InfaCare Pharmaceutical, TolerxCool Energy, Ascent Therapeutics, Dicerna Pharmaceuticals, Radius Health, Arresto BioSciences, Critical Therapeutics,Inc., Trevena, PharmAthene, BIKAM Pharmaceuticals, Adheron Therapeutics, Xanthus Pharmaceuticals, Seahorse Bioscience, CellGate, Sierra Neuropharmaceuticals Inc., CellNovo, Galleon Pharmaceuticals, RedPath Integrated Pathology, MiddleBrook Pharmaceuticals, Inc, Anchor Therapeutics, nanoMR, Cardiokine, Sequoia Pharmaceuticals, Vaxxas, Apellis Pharmaceuticals, Dynogen Pharmaceuticals, Theraclone Sciences, Aciex Therapeutics, Senseonics, SkinMedica, VaxInnate, Shape Pharmaceuticals, Pathogenetix, BioProcessors, Cleveland HeartLab, Anexon, TetraLogic Pharmaceuticals, Leap Therapeutics, Foldrx Pharmaceuticals, Promedior, Antisoma, GITR, . Over time, John Littlechild has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether John Littlechild is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Wearables, Genetics, E-commerce, Wellness, Women Founded, Investment Management, Lifestyle Products, Healthcare Innovation, Life Science, Medical Technologies, Finance, Biotechnology, Medical Devices, Fashion, Cosmetics, Genomics, Health Diagnostics, Medical, Sensors, B2B, Therapeutics, Health Tech, Pharmaceuticals, Healthcare Technology may find it worthwhile to explore potential connections with John Littlechild, as their portfolio suggests a familiarity and interest in this area.

Understanding John Littlechild’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.